In the last trading session, 1,213,497 shares of the Second Sight Medical Products, Inc.(NASDAQ:EYES) were traded, and its beta was 2.47. Most recently the company’s share price was $2.33, and it changed around -$0.11 or -0.05% from the last close, which brings the market valuation of the company to $54.09 Million. EYES currently trades at a discount to its 52-week high of $5.69, offering almost -144.21% off that amount. The share price’s 52-week low was $0.691, which indicates that the current value has risen by an impressive 70.34% since then. We note from Second Sight Medical Products, Inc.’s average daily trading volume that its 10-day average is 916.32 Million shares, with the 3-month average coming to 3.4 Million.
Second Sight Medical Products, Inc. stock received a consensus recommendation rating of Buy, based on a mean score of 2. If we narrow it down even further, the data shows that none out of 1 analysts rate the stock as a Sell; another but none rate it as Overweight. Among the rest, no body recommended EYES as a Hold, whereas 1 deemed it a Buy, and no one rated it as Underweight. Second Sight Medical Products, Inc. is expected to report earnings per share of $0 for the current quarter.
Second Sight Medical Products, Inc. (NASDAQ:EYES): Trading Information
Although EYES has showed a red trend with a performance of -4.51% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of $2.64- on Tuesday, Feb 16 increased the stock’s daily price by 11.74%. The company’s shares are currently up 0.25% year-to-date, but still down -0.0567 over the last five days. On the other hand, Second Sight Medical Products, Inc. (NASDAQ:EYES) is 0.4% up in the 30-day period. We can see from the shorts that 376.94 Million shares have been sold at a short interest cover period of 110.86 day(s).
The consensus price target as assigned by Wall Street analysts is $10, which translates to bears needing to increase their stock price by 329.18% from its current value. Analyst projections state that EYES is forecast to be at a low of $10 and a high of $10. In order for the stock price to hit the forecast high, the stock would need to surge +329.18% from its current level, while the stock would need to crash 329.18% from its current level to reach the projected low.
Second Sight Medical Products, Inc. (EYES) projections and forecasts
Consensus estimates provided by 1 financial analysts predict the company will bring in an average of $240Million in revenue for the current quarter. 1 analysts expect Second Sight Medical Products, Inc. to make $240Million in revenue for the quarter ending in Apr 2021. The company’s sales for the same quarters a year ago were $472Million and $497Million respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -49.2%. Forecasts for the next quarter put sales growth at -51.7%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 27.3%. Second Sight Medical Products, Inc. earnings are expected to increase by 46% in 2021, but the outlook is negative 0% per year for the next five years.
Second Sight Medical Products, Inc. (NASDAQ:EYES)’s Biggest Investors
Upon looking at major shareholders, it appears that insiders hold 43.09% of Second Sight Medical Products, Inc. shares, and 32.62% of them are in the hands of institutional investors. The stock currently has a share float of 57.31%. Second Sight Medical Products, Inc. stock is held by 23 institutions, with Versant Venture Management, LLC being the largest institutional investor. By Sep 29, 2020, it held 2.43% of the shares, which is about 561.61 Thousand shares worth $484.33 Thousand.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
Vanguard Group, Inc. (The), with 0.57% or 130.67 Thousand shares worth $112.69 Thousand as of Sep 29, 2020, holds the second largest percentage of outstanding shares.